New sedative showdown: which drug makes sleep apnea exams safer?
NCT ID NCT07459322
First seen Mar 17, 2026 · Last updated May 17, 2026 · Updated 11 times
Summary
This study will compare two sedative drugs, Remimazolam and Dexmedetomidine, in 60 adults undergoing Drug-Induced Sleep Endoscopy (DISE) for obstructive sleep apnea. The goal is to see which drug provides more stable sedation with fewer side effects like low heart rate or low blood pressure. Researchers will also use artificial intelligence to analyze sleep study data to better predict where airway blockages occur, helping doctors choose the best treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEDATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fu Jen Catholic University Hosptial
New Taipei City, Taiwan (r.o.c.), 24352, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.